✦ LIBER ✦

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis

✍ Scribed by Monia Marchetti; Angela Pistorio; Marisa Barone; Silvia Serafini; Giovanni Barosi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV16: COST-EFFECTIVENESS OF LOW-MOLECUL

✍ M Marchetti; A Pistorio; G Barosi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Low-Molecular-Weight Heparin versus Warf

✍ S.K. Das; A.T. Cohen; R.A. Edmondson; E. Melissari; V.V. Kakkar 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 226 KB

Comparative effectiveness of low-molecul

✍ Michael B. Rothberg; Penelope S. Pekow; Maureen Lahti; Peter K. Lindenauer 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

Low molecular weight heparin, the most c

✍ Edward Hayes; Christopher Almario; Laura Pizzi; Walter Kraft; Jason Baxter 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Community-based treatment of venous thro

✍ Thomas M. Hyers; Alex C. Spyropoulos; For the INNOVATE Investigators 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 164 KB

Low molecular weight heparin for outpati

✍ Maria M.W. Koopman; Patrick M.M. Bossuyt 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 47 KB